相关实验视频
Updated: Jun 14, 2025

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.6K
前血栓性纤维素凝块表型作为急性心肌梗塞后持续左心室血栓的危险因素
Krystian Mróz1, Elżbieta Paszek2, Maciej Polak3
1Clinical Department of Interventional Cardiology, St. John Paul II Hospital, 31-202 Krakow, Poland.
Journal of thrombosis and haemostasis : JTH
|June 12, 2025
概括
密集,难以溶解的纤维素凝块与ST段升高心肌梗塞 (MI) 患者与左心室血栓 (LVT) 的抗凝失败有关. 这些原血栓凝块特性可能与NETosis有关,影响治疗结果.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 生物化学 生化学
背景情况:
- 左心室血栓 (LVT) 影响高达15%的ST段升高心肌梗塞 (MI) 患者.
- 尽管接受抗凝血疗法,但LVT在30%的患者中可能会持续存在.
- 人们假设密集,难以溶解的纤维素凝块有助于LVT的持久性.
研究的目的:
- 调查是否不利的纤维素凝块特性与LVT分辨率有关.
- 为了确定这些纤维素凝块特性在心脏病发作患者的决定因素.
主要方法:
- 研究了149名患有LVT后心脏病发作的患者.
- 测量了纤维素凝块透性 (Ks),凝块溶解时间 (CLT),等离子素激活剂抑制剂-1 (PAI-1) 和素化组合素H3 (citH3).
- 在MI发作后3个月和6个月评估了LVT分辨率.
主要成果:
- 在3个月内持续LVT的患者Ks较低,CLT较长,PAI-1和citH3水平较高.
- 6个月后持续的LVT也显示出不利的凝块表型.
- 较低的Ks和较长的CLT独立地与LVT持久性相关.
结论:
- 血栓状纤维素凝块性质与LVT中的抗凝失败有关,导致急性MI复杂化.
- 增强的NETosis可能会导致这些不利的凝块特性.
- 这一发现是首次将凝块表型与LVT治疗耐药性联系起来.
更多相关视频
相关概念视频
Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
652
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
652
Formation of the Platelet Plug
5.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.3K
Disorders of Hemostasis
740
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
740
Extrinsic and Intrinsic Pathways of Hemostasis
6.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.5K
Coagulation
5.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.6K

